CellSource Co (TSE:4880) Asset Impairment Charge : 円0 Mil (TTM As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Asset Impairment Charge?

CellSource Co's Asset Impairment Charge for the three months ended in Jan. 2024 was 円0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jan. 2024 was 円0 Mil.

CellSource Co Asset Impairment Charge Historical Data

The historical data trend for CellSource Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Asset Impairment Charge Chart

CellSource Co Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Asset Impairment Charge

Get a 7-Day Free Trial

CellSource Co Quarterly Data
	Oct18	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

CellSource Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

CellSource Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of CellSource Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

CellSource Co (TSE:4880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002

Website

https://www.cellsource.co.jp

CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines